{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:37:12Z","timestamp":1792456632420,"version":"4.5.0"},"reference-count":41,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To assess the glycaemic efficacy and safety of CT\u2010868, a cAMP signal\u2010biased, dual glucagon\u2010like peptide\u20101\/glucose\u2010dependent insulinotropic polypeptide receptor agonist, in participants with type 2 diabetes (T2D).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>\n                      This 26\u2010week (W), phase 2, randomized, double\u2010blind placebo\u2010controlled trial enrolled adults with T2D, Body Mass Index \u226527\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , and glycated haemoglobin (HbA1c) 7.0\u201310.0%. Participants were randomized (1:2:1) to once\u2010daily CT\u2010868 1.75\u2009mg, 4.0\u2009mg, or placebo. Due to COVID\u201019\u2010related CT\u2010868 supply constraints, some participants randomized to 4.0\u2009mg received 3.25\u2009mg maximum and were analysed as a separate dose arm. The primary endpoint was change from baseline in HbA1c at W26. Secondary endpoints included changes from baseline to W26 in fasting glucose, 7\u2010point self\u2010monitored blood glucose (SMBG), body weight, lipids and the occurrence of adverse events (AEs).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 103 participants were enrolled (CT\u2010868 1.75\u2009mg,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200926; 3.25\u2009mg,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200918; 4.0\u2009mg,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200932; placebo,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200927). Clinically meaningful and statistically significant improvements in HbA1c were observed with CT\u2010868 at W26 (\u22121.61 to \u22122.24%\u2010points vs. placebo; all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Body weight was modestly reduced with CT\u2010868 4.0\u2009mg at W26 (\u22122.9% vs. placebo,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). CT\u2010868 improved fasting glucose, SMBG, and most lipid parameters vs. placebo. AEs were mostly mild\/moderate. No participants experienced hypoglycaemia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CT\u2010868 1.75 to 4.0\u2009mg yielded robust, clinically meaningful decreases in HbA1c, supporting potent glycaemic\u2010lowering effects and improved key lipid parameters in participants with overweight\/obesity and T2D, despite modest weight loss. CT\u2010868 was well tolerated, supporting future investigation of higher doses to maximize weight loss.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.70006","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T08:49:07Z","timestamp":1754383747000},"page":"1673-1682","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and safety of\n                    <scp>CT<\/scp>\n                    \u2010868, a novel, fully biased, dual glucagon\u2010like peptide\u20101\/glucose\u2010dependent insulinotropic polypeptide receptor agonist, in type 2 diabetes: A double\u2010blind, randomized placebo controlled phase 2 trial"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3699-150X","authenticated-orcid":false,"given":"Manu V.","family":"Chakravarthy","sequence":"first","affiliation":[{"name":"Roche\u2010Genentech  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0744-5472","authenticated-orcid":false,"given":"Michael A.","family":"Elliott","sequence":"additional","affiliation":[{"name":"Roche\u2010Genentech  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9439-2903","authenticated-orcid":false,"given":"Luis","family":"Acosta","sequence":"additional","affiliation":[{"name":"Roche\u2010Genentech  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1320-3128","authenticated-orcid":false,"given":"Gabriele E.","family":"Sonnenberg","sequence":"additional","affiliation":[{"name":"Roche\u2010Genentech  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9369-8193","authenticated-orcid":false,"given":"Damian","family":"Bialonczyk","sequence":"additional","affiliation":[{"name":"Roche\u2010Genentech  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3080-7012","authenticated-orcid":false,"given":"Jingtao","family":"Wu","sequence":"additional","affiliation":[{"name":"Roche\u2010Genentech  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5393-872X","authenticated-orcid":false,"given":"Federico A.","family":"Arg\u00fcelles\u2010Tello","sequence":"additional","affiliation":[{"name":"Avante\u2010Sante Research Center  San Pedro Garza Garc\u00eda Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-3568","authenticated-orcid":false,"given":"Raymundo","family":"Garcia\u2010Reza","sequence":"additional","affiliation":[{"name":"Unidad Biomedica Avanzada Monterrey  Monterrey Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6609-9483","authenticated-orcid":false,"given":"Jos\u00e9 Gerardo","family":"Gonz\u00e1lez\u2010Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Universidad Autonoma de Nuevo Leon  San Pedro Garza Garc\u00eda Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5437-2555","authenticated-orcid":false,"given":"Stig K.","family":"Hansen","sequence":"additional","affiliation":[{"name":"Kimia Therapeutics  Berkeley California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9486-1255","authenticated-orcid":false,"given":"Juan P.","family":"Frias","sequence":"additional","affiliation":[{"name":"Charles R. Drew University of Medicine and Science  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-022-00690-7"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci23-0085"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176275"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031882"},{"key":"e_1_2_10_6_1","unstructured":"Centers for Disease Control and Prevention.National Diabetes Statistics Report. US Department of Health and Human Services.2024www.cdc.gov\/diabetes\/php\/data-research\/index.htmlAccessed December 16 2024."},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01301-6"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci21-0043"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0034"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S008"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30013-X"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01324-6"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01053-X"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci24-0003"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107519"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007218"},{"issue":"1","key":"e_1_2_10_17_1","article-title":"Role of a dual glucose\u2010dependent insulinotropic peptide (GIP)\/glucagon\u2010like peptide\u20101 receptor agonist (twincretin) in glycemic control: from pathophysiology to treatment","volume":"12","author":"Pelle MC","year":"2021","journal-title":"Life (Basel)"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14496"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2014.0188"},{"key":"e_1_2_10_20_1","volume-title":"Poster Presented at the 2023 American Diabetes Association Scientific Sessions","author":"Rodriguez R","year":"2023"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03941-2"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15288"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15134"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101762"},{"key":"e_1_2_10_25_1","doi-asserted-by":"crossref","unstructured":"ChakravarthyMV HernandezM ElliottMA MaciasA HansenSK HompeschM.Weight\u2010independent effects of CT\u2010868 a signaling biased dual GLP\u20101 and GIP receptor modulator on glucose homeostasis in overweight and obese adults with type 2 diabetes. Poster presented at the 2023 American Diabetes Association Scientific Sessions; 25 June 2023; San Diego CA. Poster #774\u2010P.","DOI":"10.2337\/db23-774-P"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S002"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102156"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2025.102124"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32260-8"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0749"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-024-01460-6"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2023.11.007"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S443396"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1843"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1530\/EC-19-0144"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M006841"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14451"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000838652.68523.bc"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079908X253870"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15316"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1892"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0546"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.70006","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/full-xml\/10.1111\/dom.70006","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.70006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:00:31Z","timestamp":1773010831000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.70006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1111\/dom.70006"],"URL":"https:\/\/doi.org\/10.1111\/dom.70006","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.70006\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70006\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70006\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70006\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70006\/v2\/review3","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70006\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70006\/v1\/review4","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70006\/v1\/review3","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70006\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70006\/v2\/decision1","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"2025-05-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}